William K. Oh
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Treatment and Research 160
- Prostate Cancer Diagnosis and Treatment 34
- Renal cell carcinoma treatment 13
- Lung Cancer Treatments and Mutations 3
- Oncology 22
- Cancer Immunotherapy and Biomarkers 11
- Co-authors
- Matthew D. Galsky (96 shared papers)Philip W. Kantoff (86 shared papers)Vaibhav G. Patel (18 shared papers)Meredith M. Regan (31 shared papers)Guru Sonpavde (23 shared papers)Wanling Xie (14 shared papers)Toni K. Choueiri (14 shared papers)Che‐Kai Tsao (47 shared papers)
- Journals
- Cancer (28 papers)The Journal of Urology (22 papers)Journal of Clinical Oncology (21 papers)Clinical Genitourinary Cancer (16 papers)British Journal of Urology (14 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
William K. Oh
343 papers receiving 19.8k citations
William K. Oh's Hit Papers
Peers
Comparison fields: 5 of 115
- Pulmonary and Respiratory Medicine 7.9k
- Cancer Research 937
- Oncology 1.5k
- Surgery 2.5k
- Internal Medicine 145
Countries citing papers authored by William K. Oh
This map shows the geographic impact of William K. Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William K. Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William K. Oh more than expected).
Fields of papers citing papers by William K. Oh
This network shows the impact of papers produced by William K. Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William K. Oh. The network helps show where William K. Oh may publish in the future.
Co-authors
The 25 scholars most cited alongside William K. Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 352 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study Hit paper breakdown → | 2009 | 1741 |
| 2 | Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA Hit paper breakdown → | 2020 | 1080 |
| 3 | Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group Hit paper breakdown → | 1999 | 875 |
| 4 | Treatment of muscle‐invasive and advanced bladder cancer in 2020 Hit paper breakdown → | 2020 | 746 |
| 5 | Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy Hit paper breakdown → | 2011 | 556 |
| 6 | Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 Hit paper breakdown → | 2017 | 552 |
| 7 | PC3 is a cell line characteristic of prostatic small cell carcinoma Hit paper breakdown → | 2011 | 405 |
| 8 | 2000 | 382 | |
| 9 | Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 Hit paper breakdown → | 2020 | 309 |
| 10 | Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes Hit paper breakdown → | 2021 | 302 |
| 11 | 2011 | 272 | |
| 12 | 2015 | 265 | |
| 13 | A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer. | 2000 | 258 |
| 14 | 2011 | 241 | |
| 15 | 2018 | 236 | |
| 16 | 1998 | 228 | |
| 17 | 2013 | 223 | |
| 18 | 2017 | 219 | |
| 19 | 2020 | 219 | |
| 20 | 2009 | 203 |
About William K. Oh
William K. Oh is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Molecular Biology, having authored 352 papers that have together received 20.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (160 papers), Prostate Cancer Diagnosis and Treatment (34 papers), Bladder and Urothelial Cancer Treatments (28 papers), Renal cell carcinoma treatment (13 papers), Cancer Immunotherapy and Biomarkers (11 papers), Testicular diseases and treatments (4 papers), COVID-19 Clinical Research Studies (4 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.9k citations), Cancer Research (937 citations), Oncology (1.5k citations), Surgery (2.5k citations) and Internal Medicine (145 citations). William K. Oh has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Matthew D. Galsky, Philip W. Kantoff, Vaibhav G. Patel, Meredith M. Regan, Guru Sonpavde, Wanling Xie, Toni K. Choueiri, Che‐Kai Tsao, Noah M. Hahn and Robert Dreicer. Their work appears in journals such as Cancer, The Journal of Urology, Journal of Clinical Oncology, Clinical Genitourinary Cancer and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.